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Introduction

Cryptococcus neoformans and Cryptococcus gattii
The Cryptococcus genus is part of the basidiomycete phylum of the fungal kingdom of life. The genus contains over 50 described species, however almost all human and veterinary cases of cryptococcal infection are caused by just two species -Cryptococcus neoformans and Cryptococcus gattii.
Although these two species are closely related they present with different pathologies during infection. C. neoformans is an opportunistic pathogen of individuals with existing immune deficiencies whereas C. gattii can infect immune competent hosts. During infection both fungal species interact with host phagocytes in the lungs and phagocytosis by host alveolar macrophages provides an intracellular niche for Cryptococcus to replicate (4). However, occasionally cryptococci can escape from the macrophage via a process known as non-lytic expulsion or 'vomocytosis' (3, 5, 6). The central role of macrophages during cryptococcal infection makes this host pathogen interaction a key area of Cryptococcus research. In vitro cell culture is often used to study this interaction as in many cases, the interaction between Cryptococcus species and macrophages cultured in vitro can be used as a reliable indicator of virulence in vivo (2, 7).
Methods to quantify cryptococcal parasitism of macrophages with flow cytometry have been previously published by our lab and others (1-3). Typically, such methods exploit Cryptococcus strains with a genomic fluorescent tag (1), or a combination of antibody and cell dye stains (2, 3).
Herein we will describe our previously published method for flow cytometry analysis of cryptococcal phagocytosis by macrophages and subsequent Cryptococcus replication within the phagosome (1).
Creating fluorescently tagged Cryptococcus strains
Our protocol relies on the use of Cryptococcus strains that have been genetically modified to express a fluorescent marker protein such as green fluorescent protein (GFP). During the development of this assay we created two fluorescent strains in the H99 (C. neoformans var. grubii serotype A, genotype VNI) and R265 (C. gattii serotype B, genotype VGII) genetic backgrounds. These two strains are both common 'wild type' reference strains used by many Cryptococcus researchers.
The step by step generation the H99-GFP and R265-GFP used in this study can be found in our previous publication (1) but, in brief, cryptococci were transformed via biolistic delivery with an insertion cassette containing the GFP gene flanked upstream by the Cryptococcus JEC21 actin promoter act1 and downstream by the JEC21 tryptophan terminator trp1.
For an investigator seeking to make their own fluorescently tagged strains a number of factors must be considered once stable transformants have been produced to ensure valid results in the flow cytometry assay. It must be ensured that the insertion of the transgene and/or its expression has not significantly altered the physiology of the fluorescent mutant in comparison to its wild type parent.
This process is important as it helps to ensure the validity of all future findings using the transformed strain (see Note 1). aliquoted, once thawed discard within 2 weeks.
Materials
Cells and strains
Protocol
Experimental design
1. C. neoformans samples to be analysed by this protocol need to be fluorescently tagged.
Additionally, a sample that contains macrophages infected with a non-fluorescent C.
neoformans strain is also need as a control for the flow cytometer (see section 3.4).
Ideally this non fluorescent strain should be the same genetic background as the fluorescent Cryptococcus strain. 
Cryptococcus preparation
Long term, Cryptococcus strains can be stored at - for best results put microcentrifuge tubes on a rotator. Alternatively, C. neoformans can be opsonised with pooled human serum (separated from donor blood).
Macrophage infection
The J774 murine macrophage cell line is used here as an example, however this protocol could easily be adapted for other in vitro cell lines or in vitro cultured primary monocytes/macrophages. While the basic principles remain the same, when using this protocol for other cell types it will be important to adjust the media and growing conditions to best suit the cells used. 4. After 1 hour incubation, remove the media from each well and replace with 1 ml serum-free DMEM.
5. Infect the macrophage monolayer by adding 100 l washed and opsonised fluorescently tagged C. neoformans (1x10 7 Cryptococcus per ml, see step 3 in '3.1
Cryptococcus preparation'). Incubate for 2 hours at 37 o C, 5 % CO 2 .
6. After 2 hours incubation, aspirate the media from each well and wash gently with 
Flow cytometer setup
The setup for each flow cytometer is different. This assay was developed using a FACSCaliber (BD Biosciences), it should be possible to perform this assay using any flow cytometer that can detect GFP.
1. Take the cell suspensions from the previous step. Fix the samples by adding an equal volume of fixing media (2% formaldehyde, 2 % fetal bovine calf serum in PBS) to the accutase samples (see Note 5).
2. To setup the flow cytometer, first calibrate the instrument using a non-fluorescent control -(macrophages infected with a non fluorescent C. neoformans strain). Using the dot plot output adjust the forward scatter (FSC-H) and side scatter (SSC-H) parameters to ensure that all populations of interest are visible. Using the same nonfluorescent control also adjust the GFP detection channel (in this case FL1-H) using a histogram output to set the negative fluorescent signal to a baseline value (on most instruments this is three log 10 from the detection maximum).
3. Analyse each sample, making sure to keep the same calibration settings throughout the experiment. To enable reliable comparison between samples, collect events for each sample over a fixed period. Ideally 10,000 events should be collected for each sample to provide reliable data.
Data analysis
1. Phagocytosis -Display the collected data on a dot plot with FSC-H on the 'X' axis and FL1-H on the 'Y' axis (as in figure 2 ). The rate of phagocytosis can be calculated by comparing the number of macrophages with intracellular yeast (Figure 2 'Region2') to the number of macrophages without intracellular yeast ( Figure 2 'Region3'). lead to sub-optimal growth due to increased cellular stress. Secondly the transformed strain should be tested in a number of culture conditions and in cell culture (preferably in the same cell line which will be used for the flow cytometry assay) to check for differences to the wild type, which again could have been caused due to insertion and/ or expression of the transgene.
Intracellular proliferation -
To see the full range of tests we performed on our H99-GFP and R265-GFP strains please refer to our previous publication (1). Finally when using the strain for flow cytometry analysis it must be confirmed that the fluorescent signal of the strain is resolvable from the background auto-fluorescence which all cells display. In the case of our strains the fluorescence signal was strong and easily discernible from non-transformed strains using spectral confocal microscopy (1).
3.
For best results never split the cells less than 1/8, while passaging as sparse cell numbers affects cellular viability and potentially also immunological responses.
4.
Three to four washes are usually sufficient to remove extracellular cryptococci, gentle tapping of the plate can be performed between washes to encourage cryptococci cells to unstuck from the plate surface.
5.
While washing, care must be taken to avoid washing away macrophages -avoid pipetting liquid directly onto the growing surface, always pipette liquid down the edge of the well.
6. The protocol we describe herein is a one colour assay -needing only GFP excitation (395 nm) and emission (509 nm) filters. The filter set used for GFP is the same used for fluorescein isothiocyanate (FITC) -one of the most ubiquitous fluorophores in flow cytometry. Thus, almost all flow cytometers should be capable of analysing samples produced using the below protocol. Additional colours can be added to the protocol to allow the measurement of additional parameters such as phagocytosed / non phagocytosed cells or to measure macrophage or Cryptococcus phenotypes such as phagosomal acidification, cell viability etc.
7.
When preparing macrophage samples for flow cytometry, different volumes of accutase and fixing solution can be used to optimise sample concentration. For flow cytometry the sample concentration should be adjusted such that the number of events per second detected by the instrument is in its optimal range, this range differs between instruments. Always ensure that equal volumes of accutase and fixing media are used however.
